This is, at first sight, counterintuitive because of JMJD2D's function as a p53 coactivator, as this tumor suppressor normally reduces cell proliferation, in part by upregulating the p21 cell cycle inhibitor [57]. This evidence concerns the gene TP53 and neoplasm.